Article
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients
29 Jul 2025
Abstract excerpt
ABSTRACT: Genetic alterations alone cannot account for the diverse phenotypes of cancer cells. Even cancers with the same driver mutation show significant transcriptional heterogeneity and varied responses to therapy. However, the mechanisms underpinning this heterogeneity remain underexplored. Here, we find that novel enhancer usage is a common feature in acute lymphoblastic leukemia (ALL). In particular,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
